43.27
Bruker Corp stock is traded at $43.27, with a volume of 2.78M.
It is down -2.02% in the last 24 hours and up +15.11% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$44.16
Open:
$44.435
24h Volume:
2.78M
Relative Volume:
1.26
Market Cap:
$6.59B
Revenue:
$3.44B
Net Income/Loss:
$-8.30M
P/E Ratio:
-290.99
EPS:
-0.1487
Net Cash Flow:
$43.30M
1W Performance:
+18.91%
1M Performance:
+15.11%
6M Performance:
+3.69%
1Y Performance:
+15.33%
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
43.27 | 6.72B | 3.44B | -8.30M | 43.30M | -0.1487 |
|
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Wall Street Zen Upgrades Bruker (NASDAQ:BRKR) to Buy - MarketBeat
Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - Moomoo
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker Price Target Raised to $45.00/Share From $43.00 by TD Cowen - Moomoo
UBS Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - 富途牛牛
Bruker Is Maintained at Hold by TD Cowen - Moomoo
Bruker (NASDAQ: BRKR) Q1 2026 revenue reaches $823M amid restructuring - Stock Titan
UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating - Moomoo
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $44 to $53 - 富途牛牛
UBS Group AG Lowers Stock Holdings in Bruker Corporation $BRKR - MarketBeat
BRUKER ($BRKR) Releases Q1 2026 Earnings - Moomoo
TD Cowen Initiates Bruker Corp(BRKR.US) With Hold Rating, Announces Target Price $45 - 富途牛牛
BRUKER CORPORATION (BRKR) - MSN
Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook - Moomoo
Bruker Q1 2026 slides: beats estimates despite organic revenue decline - Investing.com
FMR LLC boosts stake in Bruker (NASDAQ: BRKR) to 12.4% - Stock Titan
Bruker Q1 Earnings Call Highlights - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Gap Up on Strong Earnings - MarketBeat
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises - Investing.com
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026Bruker Corp., Cubresa, and Siemens Healthineers Lead - Yahoo Finance UK
Full Transcript: Bruker Q1 2026 Earnings Call - Benzinga
Q1 2026 Bruker Corp Earnings Call Transcript - GuruFocus
Bruker (NASDAQ:BRKR) Beats Q1 Estimates but Maintains Cautious Full-Year Guidance Amid Organic Revenue Decline - ChartMill
Bruker shares rise 4% on first quarter earnings beat - Investing.com
Bruker shares rise 4% on first quarter earnings beat By Investing.com - Investing.com Canada
Bruker’s (NASDAQ:BRKR) Q1 CY2026: Strong Sales - Yahoo Finance UK
Bruker: Q1 Earnings Snapshot - marketscreener.com
Earnings Flash (BRKR) Bruker Corporation Posts Q1 Adjusted EPS $0.31 per Share, Vs. FactSet Est of $0.23 - Moomoo
Bruker reports Q1 2026 revenue $823.4M, non-GAAP EPS $0.31; reaffirms FY26 guidance - TradingView
Bruker (NASDAQ: BRKR) Q1 2026 revenue rises 2.7% as FY26 outlook held - Stock Titan
Bruker Reports First Quarter 2026 Financial Results - ChartMill
MSN Money - MSN
Bruker Q1 2026 Earnings Call Transcript - MarketBeat
Bruker Corp (BRKR) - MSN
Bruker earnings on deck as first quarter results loom Wednesday By Investing.com - Investing.com Canada
Bruker earnings on deck as first quarter results loom Wednesday - Investing.com
Does Earnings Jitters And Insider Selling Change The Bull Case For Bruker (BRKR)? - Yahoo Finance
Related_a1otxm - MSN
Bruker (BRKR) Price Target Lowered by Citigroup, Rating Maintained | BRKR Stock News - GuruFocus
Earnings Preview: Bruker Corp to Report Financial Results Pre-market on May 06 - Moomoo
Bruker Launches High-Throughput Molecular Diagnostic System for Infectious Diseases in Europe - Clinical Lab Products
Bruker Corp (BRKR) Shares Fall 5.4% -- What GF Score of 81 Tells Investors - GuruFocus
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Bruker (BRKR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Bruker enhances MALDI and IR Biotyper for infection control - SelectScience
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp | 8-K: Current report - Moomoo
Bruker (NASDAQ: BRKR) sets $3.9844 dividend on 6.375% preferred - Stock Titan
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):